{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-046267","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.900329+00:00","generated_at":"2026-05-30T03:48:28.725904+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"agilon health reports Q3 revenue up 28% to $1.45B but net loss widens to $118M; slashes FY2024 guidance","bullets":["Medicare Advantage members grew 37% to 525,000; total platform members 657,000 (+39% YoY).","Gross profit negative $64M vs positive $37M prior year; medical margin negative $58M vs $111M.","Adjusted EBITDA loss of $96M vs +$6M YoY; net loss $118M vs $31M.","FY2024 medical margin guidance slashed to $210-240M from $400-450M; Adj. EBITDA loss guidance widened to $155-135M.","Initiating exit of two unprofitable partnerships and other payor contracts by end of 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-046267","json":"https://secwatch.observer/filing/0001628280-24-046267.json","markdown":"https://secwatch.observer/filing/0001628280-24-046267.md","text":"https://secwatch.observer/filing/0001628280-24-046267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024046267/0001628280-24-046267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024046267/agl-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:48:28.725904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}